# Sodium Lactate in Severe TBI

> **NCT06701760** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of California, Los Angeles** · enrollment: 264 (estimated)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** Sodium Lactate
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT06701760
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2028-01-10
- **Primary completion:** 2035-12-30
- **Final completion:** 2038-07-01
- **Target enrollment:** 264 (ESTIMATED)
- **Last updated:** 2026-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06701760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06701760, "Sodium Lactate in Severe TBI". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06701760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*